Download Dr. Juan Arturo Castelán Vega - Escuela Nacional de Ciencias

Dr. Juan Arturo Castelán Vega
Associate Professor of the Biomedicine and Molecular Biotechnology Program
SNI: I From: 01/01/2014 to 31/12/2017
COFAA Fellow: Level III From: 01/01/2016 to 31/12/2018
EDI Fellow: Level VI From: 01/04/2016 to 31/03/2018
Location: Escuela Nacional de Ciencias Biológicas, IPN, Campus Lázaro Cárdenas,
Department of Microbiology, Laboratory of Production and Control of Biological
Agents “Dr. Mario González Pacheco”
Institutional Telephone: 57296300 ext. 62384 and 62575
E-mail: jcastelv@ipn.mx
Ph.D in Chemical-Biological Sciences, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional
Last publications
1. Aguilar-Madrid G, Castelán-Vega JA, Juárez-Pérez CA, Ribas-Aparicio RM, Estrada-García I, Baltierra-Jasso L,
Cervantes-Servín N, Méndez-Ortega V; Haro-García LC, Sánchez-Román FR, Ortiz-Navarrete V, Fabila-Castillo
LH, Magaña-Hernández A, Chávez-Negrete A, Salamanca-Gómez FA & A. Jiménez-Alberto. 2015.
Seroprevalence of pandemic A(H1N1)pmd09 virus antibodies in Mexican health care workers before and
after vaccination. Arch Med Res. 46(2):154-63. DOI: 10.1016/j.arcmed.2015.03.001. Epub 2015 Mar 18.
PMID: 25796508. ISSN:0188-4409.
2. Castelán-Vega JA, Magaña-Hernández A, Jiménez-Alberto A, Ribas-Aparicio RM. 2014. The hemagglutinin of
the influenza A(H1N1)pdm09 is mutating towards stability. Adv Appl Bioinform Chem. 3;7:37-44. DOI:
10.2147/AABC.S68934. ISSN: 1178-6949.
3. Jiménez-Alberto A, Alvarado-Facundo E, Ribas-Aparicio RM, Castelán-Vega JA. 2013. Analysis of adaptation
mutants in the hemagglutinin of the influenza A(H1N1)pdm09 virus. PLoS One. 8(7):e70005. DOI:
10.1371/journal.pone.0070005. ISSN: 1932-6203.
4. Jiménez-Alberto A, Parreiras P, Castelán-Vega JA, Sirota L, Arciniega J. 2011. Feasibility of the use of ELISA in
an immunogenicity-based potency test of anthrax vaccines. Biologicals. 39(4):236-41. DOI:
10.1016/j.biologicals.2011.05.001. ISSN: 1045-1056.
5. Castelán-Vega JA, Corvette L, Sirota L, Arciniega J. 2011. Reduction of immunogenicity of anthrax vaccines
subjected to thermal stress, as measured by a toxin neutralization assay. Clin Vaccine Immunol. 18(2):34951. DOI: 10.1128/CVI.00267-10. ISSN: 1556-6811.
6. Wang W, Castelán-Vega JA, Jiménez-Alberto A, Vassell R, Ye Z, Weiss CD. 2010. A mutation in the receptor
binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing
antigenicity. Virology. 407(2):374-80. DOI: 10.1016/j.virol.2010.08.027. ISSN: 0042-6822.
Participant in research Lines
1. Molecular Biotechnology
Subtopics:
1. Development of new-generation vaccines.
2. Innovation and development of biological and biotechnological products.
2. Molecular Biology
Subtopic:
1. Molecular biology of diseases impacting human and veterinary medicine, and its application on the
innovation and development of biological and biotechnological products.
Number of directes theses
Undergraduate:
MS studies:
Ph.D studies:
4
3
1
Number of participations in Meetings
National:
International:
11
9